LC
CVS icon

Lourd Capital’s CVS Health CVS Stock Holding History

Lourd Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,561
Closed -$233K – 164
2018
Q4 		$233K Buy
3,561
+892
+33% +$66.6K 0.02% 243
2018
Q3 		$210K Buy
+2,669
New +$191K 0.01% 304
2016
Q3 		– Sell
-3,598
Closed -$344K – 92
2016
Q2 		$344K Buy
3,598
+11
+0.3% +$1.1K 0.1% 71
2016
Q1 		$372K Buy
3,587
+315
+10% +$30.6K 0.04% 72
2015
Q4 		$320K Sell
3,272
-110
-3% -$10.8K 0.03% 81
2015
Q3 		$326K Buy
3,382
+157
+5% +$16.5K 0.04% 78
2015
Q2 		$338K Buy
3,225
+69
+2% +$7.05K 0.03% 84
2015
Q1 		$326K Sell
3,156
-107
-3% -$10.8K 0.03% 89
2014
Q4 		$314K Sell
3,263
-211
-6% -$18.6K 0.03% 88
2014
Q3 		$276K Buy
+3,474
New +$274K 0.03% 94
2013
Q3 		– Sell
-10,000
Closed -$572K – 108
2013
Q2 		$572K Buy
+10,000
New +$579K 0.07% 48

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lourd Capital's CVS Position: Q1 2019 in Review

Lourd Capital sold out of CVS Health (CVS) in Q1 2019, closing a stake of 3,561 shares — an estimated $233K sold.

Lourd Capital first reported a position in CVS in Q2 2013 and held it in 11 quarters. The position peaked at $572K in Q2 2013. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Lourd Capital reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Lourd Capital sold 3,561 CVS Health shares in Q1 2019, an estimated $233K.
  • Lourd Capital first reported a position in CVS Health in Q2 2013 and held it in 11 quarters.
  • Lourd Capital's CVS Health position peaked at $572K in Q2 2013.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Lourd Capital's 13F filing for Q1 2019, filed 16 Apr 2019.